Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?

Hi Grace Members,

Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?"  this Saturday, November 10, 2018 | 10:00 am– 1:00 pm Pacific time.   This seminar will be available at no charge in person and as a live webinar.

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.

Tagrisso for acquired resistance to Tarceva

My wife has come a long way with Stage IV lung cancer since 2010. She has now developed acquired resistance to Tarceva.

Gene sequence of biopsy from enlarged pre-vascular and supraclavicular lymph nodes revealed mutation remains EGFR L858R in EXON 21 (original mutation from 2011) and negative to T790M. The cancer is also PD-1 and PD-L1 negative.

Targeted therapy for Exon20

Hi Grace community,
Thank you for the extensive information and great support on your website.
It seems that after 9,5 years I have developed resistance to Alimta, which has been the main reason why I have survived so long with stage IV BAC Adenocarcinoma. Now I am at a crossroads thinking what next. Cancer has progressed in my lungs, but I'm still doing quite well.

Subscribe to Stage IV NSCLC